GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Core Laboratories Inc. /DE/ (CLB) | 10/30/2026 6:12:08 AM | Small | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Rev: $132,077,000 -1.8% | Assets $593,518,000 | EPS $0.12 | |
| Core Laboratories Inc. /DE/ (CLB) | 10/28/2026 4:25:27 PM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $132,077,000 -1.8% | Assets $593,518,000 | EPS $0.12 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 7/30/2026 5:24:46 PM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $124,609,000 -4.3% | Assets $586,778,000 | EPS $0.13 | |
| Core Laboratories Inc. /DE/ (CLB) | 7/29/2026 4:45:10 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $124,609,000 -4.3% | Assets $586,778,000 | EPS $0.13 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 5/1/2026 9:32:58 AM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $121,797,000 -1.4% | Assets $587,728,000 | EPS -$0.02 | |
| Core Laboratories Inc. /DE/ (CLB) | 4/29/2026 5:19:45 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $121,797,000 -1.4% | Assets $587,728,000 | EPS -$0.02 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 3/31/2026 5:22:30 PM | View | Proxy | SEC | Y 2025 | ||||||
| Core Laboratories Inc. /DE/ (CLB) | 3/23/2026 6:15:26 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $526,520,000 +0.5% | Assets $584,010,000 | EPS $0.63 | |
| Core Laboratories Inc. /DE/ (CLB) | 3/17/2026 6:17:13 AM | View | Correction | SEC | Y 2025 | ||||||
| Core Laboratories Inc. /DE/ (CLB) | 2/4/2026 4:59:56 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $138,255,000 +7.0% | Assets $584,010,000 | EPS $0.11 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 10/23/2025 4:13:47 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $134,521,000 +0.1% | Assets $591,360,000 | EPS $0.30 | |
| Core Laboratories Inc. /DE/ (CLB) | 10/22/2025 4:17:08 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $134,521,000 +0.1% | Assets $591,360,000 | EPS $0.30 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 7/25/2025 6:15:04 AM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $130,159,000 -0.3% | Assets $602,111,000 | EPS $0.22 | |
| Core Laboratories Inc. /DE/ (CLB) | 7/23/2025 4:23:13 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $130,159,000 -0.3% | Assets $602,111,000 | EPS $0.22 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 4/28/2025 6:15:22 AM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $123,585,000 -4.7% | Assets $591,519,000 | ||
| Core Laboratories Inc. /DE/ (CLB) | 4/23/2025 4:48:48 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $123,585,000 -4.7% | Assets $591,519,000 | Export Earnings Model | ||
| Core Laboratories Inc. /DE/ (CLB) | 3/31/2025 4:59:45 PM | View | Proxy | SEC | Y 2024 | ||||||
| Core Laboratories Inc. /DE/ (CLB) | 2/13/2025 6:15:25 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $523,848,000 +2.8% | Assets $590,406,000 | EPS $0.66 | |
| Core Laboratories Inc. /DE/ (CLB) | 1/29/2025 4:46:33 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $129,237,000 +0.8% | Assets $590,406,000 | EPS $0.16 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 10/24/2024 5:41:08 PM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $134,397,000 +7.2% | Assets $600,466,000 | EPS $0.25 | |
| Core Laboratories Inc. /DE/ (CLB) | 10/23/2024 4:33:54 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $134,397,000 +7.2% | Assets $600,466,000 | EPS $0.25 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 7/25/2024 5:16:00 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $130,577,000 +2.1% | Assets $597,799,000 | EPS $0.19 | |
| Core Laboratories Inc. /DE/ (CLB) | 7/24/2024 4:39:04 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $130,577,000 +2.1% | Assets $597,799,000 | EPS $0.19 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 4/25/2024 4:47:17 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $129,637,000 +1.0% | Assets $587,950,000 | EPS $0.07 | |
| Core Laboratories Inc. /DE/ (CLB) | 4/24/2024 4:43:34 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $129,637,000 +1.0% | Assets $587,950,000 | EPS $0.07 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 3/19/2024 6:03:49 AM | View | Proxy | SEC | Y 2023 | ||||||
| Core Laboratories Inc. /DE/ (CLB) | 2/15/2024 6:14:45 AM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $509,790,000 +4.1% | Assets $586,395,000 | EPS $0.77 | |
| Core Laboratories Inc. /DE/ (CLB) | 2/15/2024 6:06:46 AM | View | Correction | SEC | Y 2023 | ||||||
| Core Laboratories Inc. /DE/ (CLB) | 1/31/2024 5:16:54 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $128,210,000 +0.5% | Assets $586,395,000 | EPS $0.04 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 11/2/2023 4:28:16 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $125,343,000 -0.5% | Assets $592,414,000 | EPS $0.19 | |
| Core Laboratories Inc. /DE/ (CLB) | 11/1/2023 4:54:53 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $125,343,000 -0.5% | Assets $592,414,000 | EPS $0.19 | Export Earnings Model | |
| Core Laboratories Inc. /DE/ (CLB) | 7/27/2023 5:19:10 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $127,881,000 +5.8% | Assets $601,848,000 | EPS $0.48 | |
| Core Laboratories Inc. /DE/ (CLB) | 7/26/2023 4:36:44 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $127,881,000 +5.8% | Assets $601,848,000 | EPS $0.48 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/28/2023 6:20:32 AM | View | Proxy | SEC | Y 2022 | ||||||
| CORE LABORATORIES N V (CLB) | 4/27/2023 5:08:59 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $128,356,000 +11.3% | Assets $593,617,000 | EPS $0.05 | |
| CORE LABORATORIES N V (CLB) | 4/26/2023 4:59:52 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $128,356,000 +11.3% | Assets $593,617,000 | EPS $0.05 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 2/28/2023 5:33:16 PM | View | Proxy | SEC | Y 2022 | ||||||
| CORE LABORATORIES N V (CLB) | 2/10/2023 6:28:57 AM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $489,735,000 +4.1% | Assets $578,354,000 | EPS $0.42 | |
| CORE LABORATORIES N V (CLB) | 2/1/2023 5:02:08 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $127,571,000 +1.9% | Assets $578,354,000 | EPS $0.15 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/28/2022 6:09:46 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $125,966,000 +6.8% | Assets $570,190,000 | EPS $0.16 | |
| CORE LABORATORIES N V (CLB) | 10/26/2022 5:01:49 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $125,966,000 +6.8% | Assets $570,190,000 | EPS $0.16 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/28/2022 5:19:48 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $120,898,000 +1.8% | Assets $577,540,000 | EPS $0.15 | |
| CORE LABORATORIES N V (CLB) | 7/27/2022 5:01:26 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $120,898,000 +1.8% | Assets $577,540,000 | EPS $0.15 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/28/2022 5:16:57 PM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $115,300,000 +6.4% | Assets $584,918,000 | EPS -$0.04 | |
| CORE LABORATORIES N V (CLB) | 4/27/2022 5:59:38 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $115,300,000 +6.4% | Assets $584,918,000 | EPS -$0.04 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/22/2022 4:56:57 PM | View | Proxy | SEC | Y 2021 | ||||||
| CORE LABORATORIES N V (CLB) | 2/10/2022 5:01:22 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $470,252,000 -3.5% | Assets $580,853,000 | EPS $0.42 | |
| CORE LABORATORIES N V (CLB) | 2/2/2022 5:16:57 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $125,139,000 +10.0% | Assets $580,853,000 | EPS $0.06 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/29/2021 6:12:07 AM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $117,985,000 +12.0% | Assets $586,279,000 | EPS $0.02 | |
| CORE LABORATORIES N V (CLB) | 10/27/2021 4:53:22 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $117,985,000 +12.0% | Assets $586,279,000 | EPS $0.02 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/30/2021 6:14:53 AM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $118,745,000 +2.6% | Assets $598,425,000 | EPS $0.17 | |
| CORE LABORATORIES N V (CLB) | 7/28/2021 5:05:06 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $118,745,000 +2.6% | Assets $598,425,000 | EPS $0.17 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/23/2021 6:23:20 AM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $108,383,000 -28.9% | Assets $584,446,000 | EPS $0.18 | |
| CORE LABORATORIES N V (CLB) | 4/21/2021 5:06:52 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $108,383,000 -28.9% | Assets $584,446,000 | EPS $0.18 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/19/2021 4:17:40 PM | View | Proxy | SEC | Y 2020 | ||||||
| CORE LABORATORIES N V (CLB) | 2/8/2021 6:15:49 AM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $487,267,000 -27.1% | Assets $568,579,000 | EPS -$2.20 | |
| CORE LABORATORIES N V (CLB) | 1/27/2021 5:03:42 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $113,749,000 -27.4% | Assets $568,579,000 | EPS $0.30 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/22/2020 5:12:48 PM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $105,382,000 -39.2% | Assets $590,814,000 | EPS $0.07 | |
| CORE LABORATORIES N V (CLB) | 10/21/2020 5:02:04 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $105,382,000 -39.2% | Assets $590,814,000 | EPS $0.07 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/24/2020 6:14:47 AM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $115,736,000 -31.5% | Assets $614,441,000 | EPS -$0.13 | |
| CORE LABORATORIES N V (CLB) | 7/22/2020 5:01:20 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $115,736,000 -31.5% | Assets $614,441,000 | EPS -$0.13 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/24/2020 6:11:44 AM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $152,400,000 -9.9% | Assets $646,609,000 | EPS -$2.44 | |
| CORE LABORATORIES N V (CLB) | 4/22/2020 4:48:09 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $152,400,000 -9.9% | Assets $646,609,000 | EPS -$2.44 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/20/2020 2:01:28 PM | View | Proxy | SEC | Y 2019 | ||||||
| CORE LABORATORIES N V (CLB) | 2/10/2020 5:15:51 PM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $668,210,000 -4.7% | Assets $774,673,000 | EPS $2.28 | |
| CORE LABORATORIES N V (CLB) | 1/29/2020 5:14:25 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $156,778,000 -9.5% | Assets $774,673,000 | EPS $0.23 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/25/2019 6:31:17 AM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $173,200,000 -4.9% | Assets $787,696,000 | EPS $0.53 | |
| CORE LABORATORIES N V (CLB) | 10/23/2019 4:48:22 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $173,200,000 -4.9% | Assets $787,696,000 | EPS $0.53 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/26/2019 6:28:11 AM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $169,038,000 -3.7% | Assets $781,518,000 | EPS $0.61 | |
| CORE LABORATORIES N V (CLB) | 7/24/2019 5:33:06 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $169,038,000 -3.7% | Assets $781,518,000 | EPS $0.61 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/26/2019 6:24:30 AM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $169,194,000 -0.5% | Assets $791,760,000 | EPS $0.91 | |
| CORE LABORATORIES N V (CLB) | 4/24/2019 5:17:08 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $169,194,000 -0.5% | Assets $791,760,000 | EPS $0.91 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/20/2019 3:05:30 PM | View | Proxy | SEC | Y 2018 | ||||||
| CORE LABORATORIES N V (CLB) | 2/11/2019 5:09:25 PM | Small | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $700,846,000 +8.2% | Assets $648,827,000 | EPS $1.79 | |
| CORE LABORATORIES N V (CLB) | 1/30/2019 5:22:14 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $173,207,000 +1.8% | Assets $648,827,000 | EPS $0.20 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/25/2018 5:13:57 PM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $182,146,000 +11.8% | Assets $666,597,000 | EPS $0.50 | |
| CORE LABORATORIES N V (CLB) | 10/24/2018 5:05:54 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $182,146,000 +11.8% | Assets $666,597,000 | EPS $0.50 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/27/2018 6:13:37 AM | Small | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $175,475,000 +10.9% | Assets $604,744,000 | EPS $0.56 | |
| CORE LABORATORIES N V (CLB) | 7/25/2018 5:26:38 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $175,475,000 +10.9% | Assets $604,744,000 | EPS $0.56 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/27/2018 4:39:34 PM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $170,018,000 +8.6% | Assets $597,140,000 | EPS $0.53 | |
| CORE LABORATORIES N V (CLB) | 4/26/2018 6:05:34 AM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $170,018,000 +8.6% | Assets $597,140,000 | EPS $0.53 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/23/2018 12:29:41 PM | View | Proxy | SEC | Y 2017 | ||||||
| CORE LABORATORIES N V (CLB) | 2/12/2018 7:02:25 AM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $647,819,000 +9.8% | Assets $584,812,000 | EPS $1.88 | |
| CORE LABORATORIES N V (CLB) | 1/31/2018 5:23:57 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $170,111,000 +17.3% | Assets $584,812,000 | EPS $0.49 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/25/2017 6:05:14 AM | Small | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $162,887,000 +13.5% | Assets $582,744,000 | EPS $0.48 | |
| CORE LABORATORIES N V (CLB) | 10/23/2017 5:15:21 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $162,887,000 +13.5% | Assets $582,744,000 | EPS $0.48 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/26/2017 4:13:30 PM | Small | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $158,212,000 +6.9% | Assets $583,758,000 | EPS $0.51 | |
| CORE LABORATORIES N V (CLB) | 7/24/2017 4:59:47 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $158,212,000 +6.9% | Assets $583,758,000 | EPS $0.51 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/21/2017 4:55:20 PM | Small | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $156,609,000 +1.9% | Assets $580,416,000 | EPS $0.40 | |
| CORE LABORATORIES N V (CLB) | 4/19/2017 4:04:59 PM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $156,609,000 +1.9% | Assets $580,416,000 | EPS $0.40 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/24/2017 3:52:08 PM | View | Proxy | SEC | Y 2016 | ||||||
| CORE LABORATORIES N V (CLB) | 2/10/2017 4:04:41 PM | Small | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $590,232,000 -26.0% | Assets $573,052,000 | EPS $1.46 | |
| CORE LABORATORIES N V (CLB) | 1/25/2017 4:05:14 PM | View | Financials | Earnings | SEC | Y 2016 | Rev $145,033,000 -20.6% | Assets $573,052,000 | EPS $0.35 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/21/2016 4:06:21 PM | Small | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $143,483,000 -27.3% | Assets $562,138,000 | EPS $0.38 | |
| CORE LABORATORIES N V (CLB) | 10/19/2016 4:05:12 PM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $143,483,000 -27.3% | Assets $562,138,000 | EPS $0.38 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/22/2016 4:06:17 PM | Small | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $148,069,000 -27.4% | Assets $572,106,000 | EPS $0.38 | |
| CORE LABORATORIES N V (CLB) | 7/20/2016 4:06:10 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $148,069,000 -27.4% | Assets $572,106,000 | EPS $0.38 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/22/2016 5:26:27 PM | Small | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $153,647,000 -28.1% | Assets $587,250,000 | EPS $0.35 | |
| CORE LABORATORIES N V (CLB) | 4/20/2016 4:05:12 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $153,647,000 -28.1% | Assets $587,250,000 | EPS $0.35 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/23/2016 12:19:12 PM | View | Proxy | SEC | Y 2015 | ||||||
| CORE LABORATORIES N V (CLB) | 2/12/2016 4:16:33 PM | Small | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $797,520,000 -26.5% | Assets $625,258,000 | EPS $2.68 | |
| CORE LABORATORIES N V (CLB) | 1/27/2016 4:05:09 PM | View | Financials | Earnings | SEC | Y 2015 | Rev $182,723,000 -34.4% | Assets $625,258,000 | EPS $0.36 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/23/2015 4:05:46 PM | Small | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $197,265,000 -28.6% | Assets $635,105,000 | EPS $0.78 | |
| CORE LABORATORIES N V (CLB) | 10/21/2015 4:05:19 PM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $197,265,000 -28.6% | Assets $635,105,000 | EPS $0.78 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/27/2015 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $203,889,000 -23.8% | Assets $658,985,000 | EPS $0.81 | |
| CORE LABORATORIES N V (CLB) | 7/22/2015 4:05:16 PM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $203,889,000 -23.8% | Assets $658,985,000 | EPS $0.81 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/29/2015 4:05:55 PM | Small | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $213,643,000 -18.7% | Assets $630,008,000 | EPS $0.72 | |
| CORE LABORATORIES N V (CLB) | 4/22/2015 4:05:42 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $213,643,000 -18.7% | Assets $630,008,000 | EPS $0.72 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/20/2015 10:28:39 AM | View | Proxy | SEC | Y 2014 | ||||||
| CORE LABORATORIES N V (CLB) | 2/17/2015 9:26:22 AM | Small | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $1,085,222,000 +1.1% | Assets $673,325,000 | EPS $5.77 | |
| CORE LABORATORIES N V (CLB) | 1/28/2015 4:07:31 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $278,622,000 +0.8% | Assets $673,325,000 | EPS $1.51 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 11/4/2014 4:06:12 PM | Small | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $276,135,000 +1.1% | Assets $685,132,000 | EPS $1.50 | |
| CORE LABORATORIES N V (CLB) | 10/22/2014 4:07:25 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $276,135,000 +1.1% | Assets $685,132,000 | EPS $1.50 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/25/2014 4:05:36 PM | Small | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $267,562,000 +1.7% | Assets $689,128,000 | EPS $1.42 | |
| CORE LABORATORIES N V (CLB) | 7/23/2014 4:05:18 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $267,562,000 +1.7% | Assets $689,128,000 | EPS $1.42 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/25/2014 4:13:06 PM | Small | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $262,903,000 +0.8% | Assets $680,363,000 | EPS $1.35 | |
| CORE LABORATORIES N V (CLB) | 4/23/2014 4:05:25 PM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $262,903,000 +0.8% | Assets $680,363,000 | EPS $1.35 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/19/2014 9:27:20 AM | View | Proxy | SEC | Y 2013 | ||||||
| CORE LABORATORIES N V (CLB) | 2/13/2014 4:05:52 PM | Small | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $1,073,508,000 +9.4% | Assets $659,364,000 | EPS $5.28 | |
| CORE LABORATORIES N V (CLB) | 1/29/2014 4:04:41 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $276,279,000 +8.6% | Assets $659,364,000 | EPS $1.42 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/18/2013 4:04:55 PM | Small | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $273,163,000 +11.3% | Assets $657,476,000 | EPS $1.35 | |
| CORE LABORATORIES N V (CLB) | 10/16/2013 4:06:10 PM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $273,163,000 +11.3% | Assets $657,476,000 | EPS $1.35 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/19/2013 4:06:07 PM | Small | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $263,139,000 +6.5% | Assets $655,116,000 | EPS $1.29 | |
| CORE LABORATORIES N V (CLB) | 7/17/2013 4:06:52 PM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $263,139,000 +6.5% | Assets $655,116,000 | EPS $1.29 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/19/2013 4:07:43 PM | Small | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $260,927,000 +11.4% | Assets $655,443,000 | EPS $1.22 | |
| CORE LABORATORIES N V (CLB) | 4/17/2013 4:06:17 PM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $260,927,000 +11.4% | Assets $655,443,000 | EPS $1.22 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/20/2013 10:01:19 AM | View | Proxy | SEC | Y 2012 | ||||||
| CORE LABORATORIES N V (CLB) | 3/19/2013 4:02:55 PM | View | Proxy | SEC | Y 2012 | ||||||
| CORE LABORATORIES N V (CLB) | 2/19/2013 5:30:00 AM | Small | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $981,080,000 +8.1% | Assets $636,516,000 | EPS $4.54 | |
| CORE LABORATORIES N V (CLB) | 1/30/2013 4:05:28 PM | View | Financials | Earnings | SEC | Y 2012 | Rev $254,455,000 +4.4% | Assets $636,516,000 | EPS $1.17 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/19/2012 4:08:43 PM | Small | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $245,428,000 +6.1% | Assets $638,532,000 | EPS $1.14 | |
| CORE LABORATORIES N V (CLB) | 10/17/2012 4:15:33 PM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $245,428,000 +6.1% | Assets $638,532,000 | EPS $1.14 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/1/2012 4:13:42 PM | View | Guidance Update | SEC | Y 2012 | ||||||
| CORE LABORATORIES N V (CLB) | 7/20/2012 4:06:20 PM | Small | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $247,006,000 +9.4% | Assets $622,673,000 | EPS $1.11 | |
| CORE LABORATORIES N V (CLB) | 7/18/2012 4:06:06 PM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $247,006,000 +9.4% | Assets $622,673,000 | EPS $1.11 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/23/2012 4:09:24 PM | Small | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $234,191,000 +13.3% | Assets $610,678,000 | EPS $1.13 | |
| CORE LABORATORIES N V (CLB) | 4/18/2012 4:09:09 PM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $234,191,000 +13.3% | Assets $610,678,000 | EPS $1.13 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/21/2012 4:17:00 PM | View | Proxy | SEC | Y 2011 | ||||||
| CORE LABORATORIES N V (CLB) | 2/15/2012 5:22:20 PM | Small | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $907,648,000 +14.2% | Assets $610,873,000 | EPS $3.82 | |
| CORE LABORATORIES N V (CLB) | 2/1/2012 4:21:31 PM | View | Financials | Earnings | SEC | Y 2011 | Rev $243,786,000 +17.1% | Assets $610,873,000 | EPS $1.11 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/25/2011 5:26:16 PM | Small | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $231,344,000 +16.1% | Assets $562,901,000 | EPS $0.93 | |
| CORE LABORATORIES N V (CLB) | 10/19/2011 8:17:38 PM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $231,344,000 +16.1% | Assets $562,901,000 | EPS $0.93 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/19/2011 4:15:18 PM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $231,344,000 +16.1% | Assets $562,901,000 | EPS $0.93 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/29/2011 5:20:59 PM | Small | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $225,785,000 +13.5% | Assets $552,233,000 | EPS $0.83 | |
| CORE LABORATORIES N V (CLB) | 7/20/2011 4:51:00 PM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $225,785,000 +13.5% | Assets $552,233,000 | EPS $0.83 | Export Earnings Model | |
| Core Laboratories N V (CLB) | 4/22/2011 11:42:51 AM | Small | View | Financials | 10-Q | SEC | 1Q 2011 ending: 3/31/2011 | Rev: $206,733,000 +9.8% | Assets $597,274,000 | EPS $0.94 | |
| CORE LABORATORIES N V (CLB) | 4/21/2011 4:08:48 PM | Small | View | Financials | 10-K/A | SEC | Y 2010 ending: 12/31/2010 | Rev: $794,653,000 +14.2% | Assets $650,241,000 | EPS $3.00 | |
| CORE LABORATORIES N V (CLB) | 4/19/2011 4:23:29 PM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $206,733,000 +9.8% | Assets $597,274,000 | EPS $0.94 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 3/22/2011 4:43:34 PM | View | Proxy | SEC | Y 2010 | ||||||
| CORE LABORATORIES N V (CLB) | 2/22/2011 5:30:00 AM | Small | View | Financials | 10-K | SEC | Y 2010 ending: 12/31/2010 | Rev: $794,653,000 +14.2% | Assets $650,241,000 | EPS $3.00 | |
| CORE LABORATORIES N V (CLB) | 2/9/2011 4:14:55 PM | View | Financials | Earnings | SEC | Y 2010 | Rev $208,193,000 +14.6% | Assets $650,241,000 | EPS $0.81 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/26/2010 5:10:32 PM | Small | View | Financials | 10-Q/A | SEC | 3Q 2010 ending: 9/30/2010 | Rev: $199,221,000 +18.7% | Assets $645,029,000 | EPS $0.79 | |
| CORE LABORATORIES N V (CLB) | 10/20/2010 4:58:49 PM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $199,221,000 +18.7% | Assets $645,029,000 | EPS $0.79 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/20/2010 4:57:48 PM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $199,221,000 +18.7% | Assets $645,029,000 | EPS $0.79 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/20/2010 4:57:43 PM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $199,221,000 +18.7% | Assets $645,029,000 | EPS $0.79 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 7/26/2010 5:30:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2010 ending: 6/30/2010 | Rev: $198,902,000 +18.9% | Assets $652,661,000 | EPS $0.71 | |
| CORE LABORATORIES N V (CLB) | 7/21/2010 4:06:02 PM | View | Financials | Earnings | SEC | 2Q 2010 | Rev $198,902,000 +18.9% | Assets $652,661,000 | EPS $0.71 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 4/28/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Rev $188,337,000 | EPS $0.69 | Export Earnings Model | ||
| CORE LABORATORIES N V (CLB) | 4/15/2010 12:00:00 AM | View | Guidance Update | SEC | Y 2010 | ||||||
| CORE LABORATORIES N V (CLB) | 4/14/2010 4:26:06 PM | View | Proxy | SEC | Y 2009 | ||||||
| CORE LABORATORIES N V (CLB) | 2/10/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Rev $181,599,000 | Assets $658,166,000 | EPS $0.49 | Export Earnings Model | |
| CORE LABORATORIES N V (CLB) | 10/21/2009 12:00:00 AM | View | Financials | Earnings | SEC | Export Earnings Model | |||||
| CORE LABORATORIES N V (CLB) | 7/22/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Rev $167,262,000 | EPS $0.64 | Export Earnings Model | ||
| CORE LABORATORIES N V (CLB) | 4/22/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| CORE LABORATORIES N V (CLB) | 4/1/2009 4:23:28 PM | View | Proxy | SEC | Y 2008 | ||||||
| CORE LABORATORIES N V (CLB) | 2/12/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |